Pay in 4 interest-free payments of $5.98 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Actual packaging and labelling may vary
It combines a copper-binding skin-remodeling peptide with three tissue-repair and anti-inflammatory peptides bundling four compounds that researchers otherwise reconstitute and inject separately
Cagrilintide and CagriSema are investigational treatments that have not yet received regulatory approval in the UK, EU, or USA
Products sold online as AOD 9604 are frequently of unknown purity, concentration, and sterility, significantly increasing health risks beyond those seen in controlled research
US$ 20.28
US$ 26.08
US$ 29.52
US$ 26.62
US$ 20.52
US$ 29.21
US$ 24.42
